Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Neuroscience ; 164(4): 1407-21, 2009 Dec 29.
Article in English | MEDLINE | ID: mdl-19800949

ABSTRACT

Axonal dysfunction as a result of persistent demyelination has been increasingly appreciated as a cause of functional deficit in demyelinating diseases such as multiple sclerosis. Therefore, it is crucial to understand the ultimate causes of ongoing axonal dysfunction and find effective measures to prevent axon loss. Our findings related to functional deficit and functional recovery of axons from a demyelinating insult are important preliminary steps towards understanding this issue. Cuprizone diet for 3-6 wks triggered extensive corpus callosum (CC) demyelination, reduced axon conduction, and resulted in loss of axon structural integrity including nodes of Ranvier. Replacing cuprizone diet with normal diet led to regeneration of myelin, but did not fully reverse the conduction and structural deficits. A shorter 1.5 wk cuprizone diet also caused demyelination of the CC, with minimal loss of axon structure and nodal organization. Switching to normal diet led to remyelination and restored callosal axon conduction to normal levels. Our findings suggest the existence of a critical window of time for remyelination, beyond which demyelinated axons become damaged beyond the point of repair and permanent functional loss follows. Moreover, initiating remyelination early within the critical period, before prolonged demyelination-induced axon damage ensues, will improve functional axon recovery and inhibit disease progression.


Subject(s)
Axons/physiology , Corpus Callosum/physiology , Myelin Sheath/physiology , Action Potentials , Animals , Astrocytes/drug effects , Astrocytes/physiology , Axons/drug effects , Cell Adhesion Molecules, Neuronal/metabolism , Cell Lineage , Cuprizone/administration & dosage , Diet , Female , Kv1.2 Potassium Channel/metabolism , Mice , Mice, Transgenic , Microglia/drug effects , Microglia/physiology , NAV1.6 Voltage-Gated Sodium Channel , Nerve Tissue Proteins/metabolism , Oligodendroglia/drug effects , Oligodendroglia/physiology , Ranvier's Nodes/drug effects , Ranvier's Nodes/ultrastructure , Regeneration , Sodium Channels/metabolism
2.
J Membr Biol ; 186(3): 177-84, 2002 Apr 01.
Article in English | MEDLINE | ID: mdl-12148844

ABSTRACT

We analyzed the effect of culturing adult rat beta cells with NGF2.5 S for 5 to 7 days on macroscopic barium current (I(Ba)), and determined the role of Na and Ca channels on neurite-like process extension induced by NGF and dbcAMP, and by KCI depolarization. After five days in culture with 2.5S NGF, beta cells exhibit a 102% increase in I(Ba) density. This effect is on L-type calcium channels because most of the current is blocked by nifedipine. The application of NGF for 5 minutes to the cells deprived of the trophic factor for 24 hr further increases I(Ba) current by 91%. These results suggest that the trophic factor regulates I(Ba) by two different mechanisms, a) an increase in channel density and b) a rapid modulation of the channels already present in the membrane. Finally, we found that ion-channel activity modifies the growth of neurite-like processes. After 2 weeks in culture with high KCl, almost 14% of beta cells extend neurite-like processes and the most impressive effect is observed in the presence of KCl, NGF, and dbcAMP simultaneously, where nearly 60% of the cells extend neurite-like processes. Tetrodotoxin and nifedipine reduce the morphological changes induced by these agents.


Subject(s)
Calcium Channels/metabolism , Islets of Langerhans/cytology , Islets of Langerhans/metabolism , Nerve Growth Factor/metabolism , Animals , Bucladesine/pharmacology , Cells, Cultured , Islets of Langerhans/drug effects , Male , Membrane Potentials/physiology , Nerve Growth Factor/pharmacology , Neurites/drug effects , Neurites/metabolism , Neurites/physiology , Nifedipine/pharmacology , Patch-Clamp Techniques , Potassium Chloride/pharmacology , Rats , Rats, Wistar , Reference Values , Sensitivity and Specificity , Tetrodotoxin/pharmacology
3.
Mol Psychiatry ; 6(5): 511-9, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11526465

ABSTRACT

A study was made of the effects of several monoamine-uptake inhibitors on membrane currents elicited by acetylcholine (ACh-currents) generated by rat neuronal alpha2beta4 and mouse muscle nicotinic acetylcholine receptors (AChRs) expressed in Xenopus laevis oocytes. For the two types of receptors the monoamine-uptake inhibitors reduced the ACh-currents albeit to different degrees. The order of inhibitory potency was norfluoxetine > clomipramine > indatraline > fluoxetine > imipramine > zimelidine > 6-nitro-quipazine > trazodone for neuronal alpha2beta4 AChRs, and norfluoxetine > fluoxetine > imipramine > clomipramine > indatraline > zimelidine > trazodone > 6-nitro-quipazine for muscle AChRs. Thus, the most potent inhibitor was norfluoxetine, whilst the weakest ones were trazodone, 6-nitro-quipazine and zimelidine. Effects of the tricyclic antidepressant imipramine were studied in more detail. Imipramine inhibited reversibly and non-competitively the ACh-current with a similar inhibiting potency for both neuronal alpha2beta4 and muscle AChRs. The half-inhibitory concentrations of imipramine were 3.65 +/- 0.30 microM for neuronal alpha2beta4 and 5.57 +/- 0.19 microM for muscle receptors. The corresponding Hill coefficients were 0.73 and 1.2 respectively. The inhibition of imipramine was slightly voltage-dependent, with electric distances of approximately 0.10 and approximately 0.12 for neuronal alpha2beta4 and muscle AChRs respectively. Moreover, imipramine accelerated the rate of decay of ACh- currents of both muscle and neuronal AChRs. The ACh-current inhibition was stronger when oocytes, expressing neuronal alpha2beta4 or muscle receptors, were preincubated with imipramine alone than when it was applied after the ACh-current had been generated, suggesting that imipramine acts also on non-activated or closed AChRs. We conclude that monoamine-uptake inhibitors reduce ACh-currents and that imipramine regulates reversibly and non- competitively neuronal alpha2beta4 and muscle AChRs through similar mechanisms, perhaps by interacting externally on a non-conducting state of the AChR and by blocking the open receptor-channel complex close to the vestibule of the channel. These studies may be important for understanding the regulation of AChRs as well as for understanding antidepressant- and side-effects of monoamine-uptake inhibitors.


Subject(s)
Antidepressive Agents/pharmacology , Neurotransmitter Uptake Inhibitors/pharmacology , Receptors, Nicotinic/physiology , Acetylcholine/pharmacology , Animals , Biogenic Monoamines/antagonists & inhibitors , Biogenic Monoamines/metabolism , Female , Fluoxetine/pharmacology , Imipramine/pharmacology , Membrane Potentials/drug effects , Membrane Potentials/physiology , Muscle, Skeletal/physiology , Neurons/physiology , Oocytes/drug effects , Oocytes/physiology , Protein Subunits , Rats , Receptors, Nicotinic/drug effects , Receptors, Nicotinic/genetics , Recombinant Proteins/drug effects , Recombinant Proteins/metabolism , Xenopus laevis , Zimeldine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...